Skip to main content

Grupo Bafar Reports First Quarter 2026 Results

CHIHUAHUA, Mexico, April 28, 2026 (GLOBE NEWSWIRE) — Grupo Bafar, S.A.B. de C.V. (BIVA: BAFARB), a leading company and benchmark in the food sector natwide, has announced its results for the first quarter of 2026, highlighting sustained growth driven by innovation, digitalization and expansion strategies in all its divisions. First Quarter 2026 ResultsNet Sales: 8,665.8 million pesos, up 12% Operating profit: 1,369.3 million pesos, with an operating margin of 15.8% EBITDA: 1,676.7 million pesos, up 29.5% Net income: 935.1 million pesos, with a net margin of 10.8%During this quarter, Grupo Bafar presented an outstanding performance, reaching sales of $8,665.8 million pesos, which represents a growth of 12% compared to the first quarter of 2025, driven by the consolidation of new openings, the operational maturation of its own...

Continue reading

Annual report and financial statements for the year ended 31 December 2025

OCTOPUS FUTURE GENERATIONS VCT PLC Annual report and financial statements for the year ended 31 December 2025 Octopus Future Generations VCT plc (‘Future Generations VCT’ or the ‘Company’) is supporting businesses that address the most significant challenges shaping the markets of the future. The Company is managed by Octopus AIF Management Limited (the ‘Manager’), which has delegated investment management to Octopus Investments Limited (‘Octopus’ or ‘Portfolio Manager’) via its investment team Octopus Ventures. Chair’s statement I am pleased to present the financial report and audited accounts for the Company for the year to 31 December 2025. I would like to welcome all of our new shareholders to the Company and thank our existing investors for their continued support. Octopus Future Generations VCT invests in early-stage, technology-enabled...

Continue reading

Summit State Bank Earns $1,674,000, or $0.25 Per Diluted Share, in First Quarter 2026

SANTA ROSA, Calif., April 28, 2026 (GLOBE NEWSWIRE) — Summit State Bank (the “Bank”) (Nasdaq: SSBI) today reported net income of $1,674,000, or $0.25 per diluted share for the first quarter ended March 31, 2026, compared to net income of $2,494,000, or $0.37 per diluted share for the first quarter ended March 31, 2025. Pre-tax, pre-provision income was $3,320,000 for the quarter ended March 31, 2026, compared to $2,471,000 for the quarter ended March 31 2025 and $1,827,000 for the quarter ended December 31, 2025. “Our first quarter results reflect our team’s continued commitment to executing on our strategic priorities,” said Brian Reed, President and CEO. “While first quarter net income came in below the prior year, pre-tax, pre-provision income1 improved meaningfully, driven by expansion in our net interest margin, disciplined...

Continue reading

Itron Announces First Quarter 2026 Financial Results

LIBERTY LAKE, Wash., April 28, 2026 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, announced today financial results for its first quarter ended March 31, 2026. Key results for the quarter include (compared with the first quarter of 2025):Revenue of $587 million, decreased 3%; GAAP net income attributable to Itron, Inc. of $53 million, decreased $12 million; GAAP diluted earnings per share of $1.18, decreased $0.24 per share; Non-GAAP diluted EPS of $1.49, decreased $0.03 per share; Adjusted EBITDA of $92 million, increased 5%; and Free cash flow of $79 million, increased $11 million.“Itron’s first quarter results were ahead of our expectations on strong execution and certain projects running ahead of schedule, resulting in record gross...

Continue reading

Franklin Electric Reports First Quarter 2026 Results

First Quarter 2026 HighlightsConsolidated net sales of $500.4 million, an increase of 10% to the prior year Net sales increased across all three segments: 11% in Water Systems, 7% in Energy Systems, and 6% in Distribution Operating income was $48.1 million, an increase of 9% to the prior year, with operating margin of 9.6% GAAP fully diluted earnings per share (EPS) was $0.77, an increase of 15 percent; Adjusted diluted EPS was $0.831, an increase of 24 percentFORT WAYNE, Ind., April 28, 2026 (GLOBE NEWSWIRE) — Franklin Electric Co., Inc. today announced its first quarter financial results for fiscal year 2026. First quarter 2026 net sales were $500.4 million compared to first quarter 2025 net sales of $455.2 million. First quarter 2026 operating income was $48.1 million, compared to first quarter 2025 operating income of $44.1...

Continue reading

Sysco Reports Third Quarter Fiscal Year 2026 Results

HOUSTON, April 28, 2026 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY) (“Sysco” or the “company”) today announced financial results for its 13-week third fiscal quarter ended March 28, 2026. Key financial results for the third quarter of fiscal year 2026 include the following (comparisons are to the same period in fiscal year 2025):Sales increased 4.7%; U.S. Foodservice volume increased 2.3%, U.S. local volumes increased 3.3%; Gross profit increased 6.5% to $3.8 billion; Operating income decreased 9.1% to $619 million, and adjusted operating income decreased 0.6% to $768 million1; Net earnings decreased 15.2% to $340 million, and adjusted net earnings decreased 3.6% to $452 million1; Cash flow from operations increased 11% to $1.5 billion and free cash flow2 increased 19% to $1.1 billion on a year-to-date basis; EBITDA decreased...

Continue reading

Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

With recent FDA acceptance of the Phase 2a multidose portion of INLIGHT trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with higher BMI, with and without type 2 diabetes, this portion of the trial remains on track to initiate in 2Q 2026 Combination and maintenance trials of WVE-007 on track to initiate in 2026 Data from RestorAATion-2 trial of WVE-006 (GalNAc-RNA editing) in AATD (including 400 mg monthly dose and 600 mg single dose cohorts) to be presented at an investor webcast during the ATS International Conference in May 2026 Regulatory feedback on accelerated approval pathway for WVE-006 continues to be expected mid-2026 CTA submission for WVE-008 (GalNAc-RNA editing for PNPLA3 I148M liver disease) on track for 2026 Well capitalized with cash and cash equivalents of $544.6 million as of March 31, 2026 and expected cash runway...

Continue reading

Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution

– ARCALYST® (rilonacept) Q1 2026 net product revenue of $214.3 million, representing 56% year-over-year growth –– ARCALYST 2026 expected net product revenue increased to $930 – $945 million –– KPL-387 Phase 2 recurrent pericarditis data expected in 2H 2026; Phase 3 pivotal trial expected to initiate by year-end –– Q1 2026 cash balance increased to $468.1 million – – Conference call and webcast scheduled for 8:30 am ET today – LONDON, April 28, 2026 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications, today reported first quarter 2026 financial results and recent portfolio execution. “Five years from launch, Kiniksa continues to deliver strong...

Continue reading

reAlpha (Nasdaq: AIRE) Reports First-Quarter 2026 Financial Results

Platform enters spring homebuying season with broader service coverage, a newly launched Homebuying Hub, and Total Transaction Volume that more than doubled year-over-year DUBLIN, Ohio, April 28, 2026 (GLOBE NEWSWIRE) — reAlpha Tech Corp. (Nasdaq: AIRE) (the “Company” or “reAlpha”), an AI-powered real estate technology company, today announced financial results for the first quarter ended March 31, 2026. Financial Highlights (All figures are approximate and compared to Q1 2025 unless otherwise stated)Revenue decreased 9% to $0.8 million in the first quarter of 2026, compared to $0.9 million in the first quarter of 2025.Homebuying Services Segment revenue was $0.6 million, compared to $0.8 million in the prior year period, reflecting contributions from reAlpha Mortgage and Prevu, which was acquired in November 2025, and partially...

Continue reading

TransUnion Announces Strong First Quarter 2026 Results

Exceeded revenue, Adjusted EBITDA and Adjusted Diluted Earnings Per Share guidance Delivered 14 percent revenue growth, or 11 percent organic constant currency, led by U.S. Financial Services Completed the acquisition of majority ownership interest in Trans Union de Mexico Raising our full year 2026 financial guidance to reflect recent acquisitions while maintaining our organic constant currency growth assumptionsCHICAGO, April 28, 2026 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) (the “Company”) today announced financial results for the quarter ended March 31, 2026. First Quarter 2026 Results Revenue:Total revenue for the quarter was $1,246 million, an increase of 14 percent (13 percent on a constant currency basis and 11 percent on an organic constant currency basis), compared with the first quarter of 2025.Earnings:Net...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.